ICON PLC (ICLR) Stock Fundamental Analysis
USA - NASDAQ:ICLR - IE0005711209 - Common Stock
182.03 USD
+3.92 (+2.2%)
182.03 USD
0 (0%)
We assign a fundamental rating of 5 out of 10 to ICLR. ICLR was compared to 58 industry peers in the Life Sciences Tools & Services industry. ICLR has an average financial health and profitability rating. ICLR is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
ICLR had positive earnings in the past year.
ICLR had a positive operating cash flow in the past year.
ICLR had positive earnings in each of the past 5 years.
In the past 5 years ICLR always reported a positive cash flow from operatings.
1.2 Ratios
ICLR's Return On Assets of 3.63% is fine compared to the rest of the industry. ICLR outperforms 74.14% of its industry peers.
ICLR has a Return On Equity of 6.42%. This is in the better half of the industry: ICLR outperforms 75.86% of its industry peers.
ICLR has a better Return On Invested Capital (6.74%) than 75.86% of its industry peers.
ICLR had an Average Return On Invested Capital over the past 3 years of 5.80%. This is significantly below the industry average of 14.43%.
The 3 year average ROIC (5.80%) for ICLR is below the current ROIC(6.74%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.63% | ||
| ROE | 6.42% | ||
| ROIC | 6.74% |
ROA(3y)3.74%
ROA(5y)4.36%
ROE(3y)6.96%
ROE(5y)8.15%
ROIC(3y)5.8%
ROIC(5y)6.92%
1.3 Margins
ICLR has a Profit Margin of 7.40%. This is in the better half of the industry: ICLR outperforms 70.69% of its industry peers.
ICLR's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 13.99%, ICLR is in the better half of the industry, outperforming 74.14% of the companies in the same industry.
ICLR's Operating Margin has been stable in the last couple of years.
The Gross Margin of ICLR (28.13%) is worse than 75.86% of its industry peers.
In the last couple of years the Gross Margin of ICLR has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.99% | ||
| PM (TTM) | 7.4% | ||
| GM | 28.13% |
OM growth 3Y9.91%
OM growth 5Y-0.95%
PM growth 3Y50.65%
PM growth 5Y-6.44%
GM growth 3Y2.3%
GM growth 5Y-0.09%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ICLR is destroying value.
ICLR has less shares outstanding than it did 1 year ago.
The number of shares outstanding for ICLR has been increased compared to 5 years ago.
The debt/assets ratio for ICLR has been reduced compared to a year ago.
2.2 Solvency
ICLR has an Altman-Z score of 2.09. This is not the best score and indicates that ICLR is in the grey zone with still only limited risk for bankruptcy at the moment.
ICLR's Altman-Z score of 2.09 is in line compared to the rest of the industry. ICLR outperforms 48.28% of its industry peers.
ICLR has a debt to FCF ratio of 3.53. This is a good value and a sign of high solvency as ICLR would need 3.53 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.53, ICLR is in the better half of the industry, outperforming 72.41% of the companies in the same industry.
ICLR has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.31, ICLR is in line with its industry, outperforming 48.28% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 3.53 | ||
| Altman-Z | 2.09 |
ROIC/WACC0.83
WACC8.14%
2.3 Liquidity
A Current Ratio of 1.06 indicates that ICLR should not have too much problems paying its short term obligations.
ICLR has a worse Current ratio (1.06) than 84.48% of its industry peers.
A Quick Ratio of 1.06 indicates that ICLR should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.06, ICLR is not doing good in the industry: 77.59% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.06 | ||
| Quick Ratio | 1.06 |
3. Growth
3.1 Past
The earnings per share for ICLR have decreased by -5.99% in the last year.
The Earnings Per Share has been growing by 15.23% on average over the past years. This is quite good.
The Revenue has decreased by -2.46% in the past year.
The Revenue has been growing by 24.17% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-5.99%
EPS 3Y13.76%
EPS 5Y15.23%
EPS Q2Q%-1.19%
Revenue 1Y (TTM)-2.46%
Revenue growth 3Y14.75%
Revenue growth 5Y24.17%
Sales Q2Q%0.63%
3.2 Future
The Earnings Per Share is expected to grow by 7.20% on average over the next years.
ICLR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.41% yearly.
EPS Next Y-3.7%
EPS Next 2Y1.02%
EPS Next 3Y3.55%
EPS Next 5Y7.2%
Revenue Next Year-3.61%
Revenue Next 2Y-1%
Revenue Next 3Y0.97%
Revenue Next 5Y2.41%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 13.80, the valuation of ICLR can be described as correct.
Compared to the rest of the industry, the Price/Earnings ratio of ICLR indicates a rather cheap valuation: ICLR is cheaper than 98.28% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.08, ICLR is valued a bit cheaper.
With a Price/Forward Earnings ratio of 12.74, ICLR is valued correctly.
Based on the Price/Forward Earnings ratio, ICLR is valued cheaper than 98.28% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of ICLR to the average of the S&P500 Index (23.09), we can say ICLR is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.8 | ||
| Fwd PE | 12.74 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ICLR is valued cheaper than 100.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ICLR is valued cheaper than 94.83% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.68 | ||
| EV/EBITDA | 11.03 |
4.3 Compensation for Growth
The decent profitability rating of ICLR may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.91
EPS Next 2Y1.02%
EPS Next 3Y3.55%
5. Dividend
5.1 Amount
No dividends for ICLR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
182.03
+3.92 (+2.2%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners102.62%
Inst Owner Change-0.08%
Ins Owners0.65%
Ins Owner ChangeN/A
Market Cap14.16B
Revenue(TTM)8.10B
Net Income(TTM)599.48M
Analysts78.4
Price Target220.12 (20.93%)
Short Float %2.91%
Short Ratio2.2
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.77%
Min EPS beat(2)-1.21%
Max EPS beat(2)-0.34%
EPS beat(4)1
Avg EPS beat(4)-0.63%
Min EPS beat(4)-1.21%
Max EPS beat(4)0.23%
EPS beat(8)1
Avg EPS beat(8)-2.34%
EPS beat(12)2
Avg EPS beat(12)-1.79%
EPS beat(16)5
Avg EPS beat(16)-1.4%
Revenue beat(2)1
Avg Revenue beat(2)0.4%
Min Revenue beat(2)-0.23%
Max Revenue beat(2)1.03%
Revenue beat(4)1
Avg Revenue beat(4)-0.84%
Min Revenue beat(4)-2.61%
Max Revenue beat(4)1.03%
Revenue beat(8)1
Avg Revenue beat(8)-2.24%
Revenue beat(12)1
Avg Revenue beat(12)-2.14%
Revenue beat(16)1
Avg Revenue beat(16)-2.06%
PT rev (1m)0%
PT rev (3m)22.52%
EPS NQ rev (1m)-0.5%
EPS NQ rev (3m)-2.27%
EPS NY rev (1m)-0.07%
EPS NY rev (3m)-0.31%
Revenue NQ rev (1m)-0.3%
Revenue NQ rev (3m)0.05%
Revenue NY rev (1m)-0.12%
Revenue NY rev (3m)0.36%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.8 | ||
| Fwd PE | 12.74 | ||
| P/S | 1.75 | ||
| P/FCF | 14.68 | ||
| P/OCF | 12.41 | ||
| P/B | 1.52 | ||
| P/tB | N/A | ||
| EV/EBITDA | 11.03 |
EPS(TTM)13.19
EY7.25%
EPS(NY)14.29
Fwd EY7.85%
FCF(TTM)12.4
FCFY6.81%
OCF(TTM)14.66
OCFY8.06%
SpS104.19
BVpS120.03
TBVpS-38.28
PEG (NY)N/A
PEG (5Y)0.91
Graham Number188.74
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.63% | ||
| ROE | 6.42% | ||
| ROCE | 8.53% | ||
| ROIC | 6.74% | ||
| ROICexc | 6.98% | ||
| ROICexgc | 176.34% | ||
| OM | 13.99% | ||
| PM (TTM) | 7.4% | ||
| GM | 28.13% | ||
| FCFM | 11.9% |
ROA(3y)3.74%
ROA(5y)4.36%
ROE(3y)6.96%
ROE(5y)8.15%
ROIC(3y)5.8%
ROIC(5y)6.92%
ROICexc(3y)5.97%
ROICexc(5y)8.67%
ROICexgc(3y)88.82%
ROICexgc(5y)90.84%
ROCE(3y)7.34%
ROCE(5y)8.76%
ROICexgc growth 3Y-4.45%
ROICexgc growth 5Y-5.01%
ROICexc growth 3Y27.99%
ROICexc growth 5Y-24.17%
OM growth 3Y9.91%
OM growth 5Y-0.95%
PM growth 3Y50.65%
PM growth 5Y-6.44%
GM growth 3Y2.3%
GM growth 5Y-0.09%
F-Score6
Asset Turnover0.49
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 3.53 | ||
| Debt/EBITDA | 1.89 | ||
| Cap/Depr | 45.31% | ||
| Cap/Sales | 2.17% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 74.92% | ||
| Profit Quality | 160.84% | ||
| Current Ratio | 1.06 | ||
| Quick Ratio | 1.06 | ||
| Altman-Z | 2.09 |
F-Score6
WACC8.14%
ROIC/WACC0.83
Cap/Depr(3y)27.79%
Cap/Depr(5y)38.09%
Cap/Sales(3y)1.87%
Cap/Sales(5y)1.83%
Profit Quality(3y)130.43%
Profit Quality(5y)205.36%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.99%
EPS 3Y13.76%
EPS 5Y15.23%
EPS Q2Q%-1.19%
EPS Next Y-3.7%
EPS Next 2Y1.02%
EPS Next 3Y3.55%
EPS Next 5Y7.2%
Revenue 1Y (TTM)-2.46%
Revenue growth 3Y14.75%
Revenue growth 5Y24.17%
Sales Q2Q%0.63%
Revenue Next Year-3.61%
Revenue Next 2Y-1%
Revenue Next 3Y0.97%
Revenue Next 5Y2.41%
EBIT growth 1Y-0.88%
EBIT growth 3Y26.12%
EBIT growth 5Y22.99%
EBIT Next Year0.82%
EBIT Next 3Y3.29%
EBIT Next 5Y4.05%
FCF growth 1Y86.71%
FCF growth 3Y15.01%
FCF growth 5Y25.32%
OCF growth 1Y72.39%
OCF growth 3Y15.78%
OCF growth 5Y25.55%
ICON PLC / ICLR FAQ
Can you provide the ChartMill fundamental rating for ICON PLC?
ChartMill assigns a fundamental rating of 5 / 10 to ICLR.
What is the valuation status of ICON PLC (ICLR) stock?
ChartMill assigns a valuation rating of 6 / 10 to ICON PLC (ICLR). This can be considered as Fairly Valued.
Can you provide the profitability details for ICON PLC?
ICON PLC (ICLR) has a profitability rating of 6 / 10.
How financially healthy is ICON PLC?
The financial health rating of ICON PLC (ICLR) is 5 / 10.
What is the earnings growth outlook for ICON PLC?
The Earnings per Share (EPS) of ICON PLC (ICLR) is expected to decline by -3.7% in the next year.